Cite
HARVARD Citation
White, W. et al. (n.d.). Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus1. Diabetes, obesity & metabolism. 15 (7), pp. 668-673. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
White, W. et al. (n.d.). Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus1. Diabetes, obesity & metabolism. 15 (7), pp. 668-673. [Online].